What Do You Need to Know About Welltower (WELL) Before Investing?

Large-cap Real Estate company Welltower has moved 0.4% so far today on a volume of 1,493,357, compared to its average of 3,194,590. In contrast, the S&P 500 index moved 0.0%.

Welltower trades -3.91% away from its average analyst target price of $91.65 per share. The 17 analysts following the stock have set target prices ranging from $78.0 to $101.0, and on average have given Welltower a rating of buy.

Anyone interested in buying WELL should be aware of the facts below:

  • Welltower's current price is 339.3% above its Graham number of $20.05, which implies that at its current valuation it does not offer a margin of safety

  • Welltower has moved 33.5% over the last year, and the S&P 500 logged a change of 15.4%

  • Based on its trailing earnings per share of 0.53, Welltower has a trailing 12 month Price to Earnings (P/E) ratio of 166.2 while the S&P 500 average is 15.97

  • WELL has a forward P/E ratio of 73.4 based on its forward 12 month price to earnings (EPS) of $1.2 per share

  • The company has a price to earnings growth (PEG) ratio of 1.81 — a number near or below 1 signifying that Welltower is fairly valued compared to its estimated growth potential

  • Its Price to Book (P/B) ratio is 2.04 compared to its sector average of 2.1

  • Welltower Inc. (NYSE:WELL), a real estate investment trust ("REIT") and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure.

  • Based in Toledo, the company has 514 full time employees and a market cap of $48.74 Billion. Welltower currently returns an annual dividend yield of 2.8%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.